Healthtech funding in Q3 2019
European Healthtech startup funding raised during Q3 2019.
In Q3 2019, 38 European Healthtech companies closed 38 funding rounds and raised €1.0B in equity funding (excluding debt and grants), up 202.5% versus Q3 2018. UK led by capital raised, and Sofinnova Partners was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.0B
+202.5% vs Q3 2018 · excl. debt & grants
Funding rounds
38
-17.4% vs Q3 2018
Companies
38
Top country
UK
Rank among sectors
#3
12.3% of sector funding
Top-10 round share
90.2%
of disclosed capital
Rounds ≥ €100M
2
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q3 2019 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €1.0B | 37 |
| Aug | €1.1M | 1 |
Top countries
by € raisedHealthtech — top countries by capital, Q3 2019 — interactive chart.
Data table
| Healthtech — top countries by capital, Q3 2019 | |
|---|---|
| UK | €770M |
| France | €64M |
| Belgium | €47M |
| Israel | €44M |
| Sweden | €19M |
| Netherlands | €15M |
| Germany | €14M |
| Denmark | €13M |
Stage mix
by € raisedHealthtech — stage mix, Q3 2019 — interactive chart.
Data table
| Healthtech — stage mix, Q3 2019 | |
|---|---|
| Other | €560M |
| Series C | €319M |
| Series A | €49M |
| Series D+ | €44M |
| Series B | €24M |
| Seed | €7.5M |
| Pre-Seed | €2.0M |
Exits & M&A
4 Acquisition4 exits.
Top deals
largest disclosed rounds in Q3 2019| Company | Stage | Date | Amount |
|---|---|---|---|
| Babylon | Other | Jul 2019 | €483M |
| CMR Surgical | Series C | Jul 2019 | €218M |
| PolyPid | Series D+ | Jul 2019 | €44M |
| Quanta | Series C | Jul 2019 | €42M |
| iSTAR Medical | Series C | Jul 2019 | €40M |
| Microphyt | Other | Jul 2019 | €29M |
| Citryll | Series A | Jul 2019 | €15M |
| Doktor | Other | Jul 2019 | €14M |
| GNA Biosolutions | Series C | Jul 2019 | €12M |
| AFYX Therapeutics | Other | Jul 2019 | €11M |
| PredictImmune | Series B | Jul 2019 | €11M |
| AblaCare | Series A | Jul 2019 | €10M |
| Osivax | Series A | Jul 2019 | €8.0M |
| Creoptix | Series C | Jul 2019 | €7.2M |
| CryoTherapeutics | Series B | Jul 2019 | €7.0M |
Top investors
most active in Q3 2019, by deal count- Sofinnova Partners2 deals
- Almi Invest1 deals
- Antoine Papiernik1 deals
- Archangels1 deals
- Barnaby Cardwell1 deals
- Beat Curti1 deals
- BioInnovation Institute1 deals
- Bpifrance1 deals
- BStartup1 deals
- btov Partners1 deals